You are here

  • Home
  • Archive
  • Volume 69, Issue 5
  • Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis

Authors

  1. Correspondence to Lilian HD van Tuyl, VU University Medical Center, Department of Rheumatology, ZH-3A-56, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands; L.vantuyl{at}vumc.nl
View Full Text

Citation

van Tuyl LHD, Boers M, Lems WF, et al
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis
Annals of the Rheumatic Diseases 2010;69:807-812.

Publication history

  • Accepted April 30, 2009
  • First published May 17, 2009.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions